Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(ShareCast News) - Pharmaceutical and biologics company AstraZeneca announced on Thursday that it has entered into a licensing agreement with Grünenthal GmbH for the exclusive rights to Zurampic (lesinurad) in Europe and Latin America. The FTSE 100 firm received approval from the European Medicines
2 Jun 16 07:08LONDON, June 2 (Reuters) - AstraZeneca has sold the European and Latin American rights to its new gout drug Zurampic to private German drugmaker Gruenenthal for up to $230 million, following a similar disposal of U.S. rights to the medicine. The British group said on Thursday up it would re
2 Jun 16 06:52(ShareCast News) - AstraZeneca, the UK's second-biggest drug developer, will this week outline its next big hope in the battle against cancer by unveiling new data on a class of treatments, known as DNA damage response (DDR) medicines, at a conference in Chicago. The drugs work by stopping cancerous
29 May 16 16:22(Repeats May 27 story with no changes) By Bill Berkrot NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial
29 May 16 11:00By Bill Berkrot NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the inves
27 May 16 23:52
27 May 16 11:44(Adds analyst comment, further details) LONDON, May 27 (Reuters) - AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion last
27 May 16 08:53(ShareCast News) - Phamaceuticals giant AstraZeneca announced positive results for its Faslodex drug for the treatment of metastatic breast cancer, but also said US regulators will not currently approve its new drug for high potassium levels because of a manufacturing issue. The company said on Frid
27 May 16 07:32(ShareCast News) - Stocks are set for a slightly lower open as traders tread cautiously ahead of a speech by Fed chair Janet Yellen towards the close of trading in London and ahead of the release of key economic indicators Stateside. The fact that investors are heading into a long weekend on both si
27 May 16 07:29LONDON, May 27 (Reuters) - AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion last year. The British drugmaker said the Fo
27 May 16 06:36SHANGHAI, May 27 (Reuters) - China will carry out wide-ranging pricing inspections on drug firms, hospitals and procurement bodies from June 1, the country's top watchdog said on Friday, extending a tough cost-cutting campaign to reduce the price of healthcare. The National Development and
27 May 16 02:42(Adds details, comments from FDA reviewers) By Toni Clarke May 23 (Reuters) - A preliminary review by the U.S. Food and Drug Administration questioned the usefulness of a combination diabetes drug made by Sanofi SA's and said it was unclear whether one component, lixisenatide, contrib
23 May 16 17:05(Updates with details) May 23 (Reuters) - A preliminary review by the U.S. Food and Drug Administration questioned whether Sanofi SA's experimental diabetes drug lixisenatide contributed any benefit to a fixed-dose combination product the company hopes to market. The review comes ahe
23 May 16 13:45
Last checked at